Latest filing published 03 Jan 2017 for ClearPoint Neuro, Inc., €4,496.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +34.2%Entry US$30.40 · Close at T+365 US$40.80
- +41.1%Entry US$29.20 · Close at T+365 US$41.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andrew K. Rooke: trading record in brief
Andrew K. Rooke appears in our data through filings on ClearPoint Neuro, Inc. shares, published by SEC (Form 4). The record holds 23 filings, for trades running from 17 June 2013 to 30 December 2016.
No open-market sale appears; the market trades are 4 purchases worth €45k. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 18 share grants.
Most recently, on 3 January 2017, the filings show a share grant worth €4,496 in ClearPoint Neuro, Inc. The most recent open-market purchase was published on 7 September 2016, 3,714 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew K. Rooke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,801 shares@ US$2.6428.3% of flowCommon StockSEC:0001534424-17-000016:0
- 638 shares@ US$6.6523.8% of flowCommon StockSEC:0001534424-16-001071:0
- 10,000 sharesCommon StockSEC:0001534424-16-001013:0Canonical exit: 1 Dec 2016 (T+90)
- 200,000 sharesCommon StockSEC:0001534424-16-001013:1
- 20,457 shares@ US$0.2124.3% of flowCommon StockSEC:0001534424-16-000865:0
- 13,817 shares@ US$0.3123.7% of flowCommon StockSEC:0001534424-16-000686:0
- 12,512 sharesCommon StockSEC:0001534424-16-000481:0
- 154,035 sharesCommon StockSEC:0001534424-15-000458:0Canonical exit: 17 Mar 2016 (T+90)
- 7,084 shares@ US$0.60Common StockSEC:0001534424-15-000312:0
- 3,945 shares@ US$1.08Common StockSEC:0001437749-15-013284:0
- 4,750 shares@ US$1.00Common StockSEC:0001437749-15-006733:0
- 5,510 shares@ US$0.862Common StockSEC:0001437749-15-000181:0
- 3,455 shares@ US$1.23Common StockSEC:0001437749-14-017793:0
- 4,656 shares@ US$1.02Common StockSEC:0001437749-14-012263:0
- 30,000 shares@ US$0.73Common StockSEC:0001437749-14-011209:0Canonical exit: 11 Sept 2014 (T+90)
- 50,000 shares@ US$0.7842Common StockSEC:0001437749-14-011087:0Canonical exit: 8 Sept 2014 (T+90)
- 4,153 shares@ US$1.24Common StockSEC:0001437749-14-005948:0
- 4,135 shares@ US$1.33Common StockSEC:0001437749-14-000147:0
- 3,191 shares@ US$1.41Common StockSEC:0001437749-13-012563:0
- 400,000 shares@ US$0.01Common StockSEC:0001437749-13-009060:0
- 125,000 shares@ US$0.01Common StockSEC:0001437749-13-009060:1
- 9,090 shares@ US$1.10Common StockSEC:0001437749-13-008273:0
- 400,000 shares@ US$0.01Common StockSEC:0001140361-13-025518:0
23 of 23 declarations
